Successful partnerships, from early-stage science to commercialization, have been one of the main drivers in establishing Lundbeck’s current position in brain science. 

Lundbeck is globally recognized as one of the leading companies within neurological and psychiatric disorders and is one of the only fully integrated pharmaceutical companies focused solely within brain diseases. Restoring brain health requires a concerted effort, and we are committed to developing new and better treatment options from innovations born in house and externally.

Lundbeck’s long experience and continuous work within brain diseases have provided us with a strong global network in preclinical and clinical neuroscience research. Partnering with external specialists in their respective fields of brain disease is a cornerstone of our strategy, and we always strive to be the partner of choice. Lundbeck holds the knowledge, capabilities and financial stability to spur innovation, both through our internal laboratories and external partners.

We enter into partnerships recognizing that your business strengths are different and complementary to our own. This is why we customize each partnership to ensure value creation and to translate today’s know-how into tomorrow’s advancements in life-changing therapies.

We actively seek access to external innovation, particularly where we see best-in-class opportunities to develop transformative medicines, and where we can leverage our own global drug development and commercial expertise to bring new medicines to patients.

Our primary ambition is to find innovative projects and products that will advance neuroscience and develop novel and innovative treatments for patients. By combining our internal R&D capabilities with external alliances, we significantly broaden the opportunities to achieve our end goal. Opportunities in scope include:

• Discovery technology platforms
• Enabling technologies, such as biomarkers and imaging
• Digital platforms, such as wearables
• Discovery projects
• Pre-clinical projects
• Early and mid-stage developments projects
• Regional and global commercialized products

Global business development and strategy consists of two teams

We have a rigorous process to screen, assess, and execute on external  opportunities ranging from technologies, pipeline assets, and company acquisitions. We use a tried-and-tested cross-functional approach to conduct an effective in-depth evaluation of every business development opportunity.

Our team works closely with internal stakeholders and subject matter experts to ensure an agile exchange, knowledge sharing and fast decision making.

In this way, we aim to create the strongest possible foundation for a mutual understanding of how to shape the market for tomorrow.

Our established business development process has four key stages:

The treatments we have launched over the last 10 years demonstrate Lundbeck’s ability and commitment to establishing exceptional partnerships. We collaborate with companies, academic institutions, individuals, and third parties from round the world. Lundbeck has around 80-100 scientific and commercial partnerships and collaborations.